Antiphospholipid Antibodies in Lupus Nephritis.
Lupus nephritis (LN) is a major manifestation of systemic lupus erythematosus (SLE). It remains unclear whether antiphospholipid antibodies (aPL) alter the course of LN. We thus investigated the impact of aPL on short-term and long-term renal outcomes in patients with LN. We assessed levels of aPL c...
Main Authors: | Ioannis Parodis, Laurent Arnaud, Jakob Gerhardsson, Agneta Zickert, Birgitta Sundelin, Vivianne Malmström, Elisabet Svenungsson, Iva Gunnarsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4919007?pdf=render |
Similar Items
-
Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
by: Ioannis Parodis, et al.
Published: (2019-01-01) -
Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis.
by: Karin Bolin, et al.
Published: (2013-01-01) -
Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
by: Elisabet Svenungsson, et al.
Published: (2021-07-01) -
Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.
by: Hironari Hanaoka, et al.
Published: (2018-01-01) -
Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
by: Myriam Martin, et al.
Published: (2020-10-01)